Artemis Medicare Services Ltd

Filing Status

• Show Cause Notice received from the CGST Office, Gurugram, dated September 28, 2026.
• Period covered: April 1, 2022 to March 31, 2023.
• Allegation: charging MRP from IPD on medicines, consumables, implants, with GST not remitted.
• Estimated financial impact: Rs 11.11 crore plus interest and penalties.
• Filing a writ to connect with earlier stay by the Hon'ble Punjab & Haryana High Court.
• Annexure A contains true, correct information as per Company.

Show Cause Notice

• Show Cause Notice dated September 28, 2026 received from the CGST office, Gurugram.
• Period covered: April 1, 2022 to March 31, 2023.
• Allegation: charging MRP to IPD patients for medicines/consumables/implants with GST not remitted.
• Potential financial impact: Rs 11.11 crore plus interest and penalty.
• Company had earlier filed a writ; High Court stay on related proceedings.
• Company to file another writ to connect with the prior matter.

Artemis Medicare Services Limited trading window closed from Oct 1, 2026 until 48 hours after the declaration of financial results for the quarter ending September 30, 2026

Meeting Details

• Date: Thursday, September 3, 2026
• Type and mode: Group investor conference, physical in Delhi
• Event organizer: PhillipCapital's Market Marvel investor conference (Investing Beyond the Headlines)
• Company representatives will participate
• Purpose: Analysts and institutional investor interaction at conference

Financial Performance

• Consolidated revenue for Q1 FY27: INR 287.32 crores, up 12.7% YoY.
• Standalone Gurgaon revenue grew 15.4% YoY.
• EBITDA for Q1: INR 61.82 crores, margin 21.5%.
• PAT for Q1: INR 31.44 crores, up 48.3% YoY.

Operational Update

• Gurugram occupancy 65.7%, ARPOB INR 85,690.
• Raipur 300-bed hospital commenced operations; OPD July 9; theatres and cath labs July 27.
• International patients accounted for ~27% of international business in Q1.

Capex and Projects

• Tower IV Gurgaon: 200+ beds, 18–22 months to full operation.
• Total bed capacity target: 2,000 by 2029‑2030.
• Capex over next three years ~INR 800 crores; Raipur ~INR 120 crores; VIMHANS ~INR 350–360 crores.
• Tower IV capex per bed ~INR 55 lakhs; 200 beds.

Guidance and Outlook

• Raipur insurance empanelment expected in 8–10 weeks; cashless intermediaries in place till then.
• Raipur ramp-up expected 20–25% faster post-empanelment.
• QIP of INR 700 crores enabling expansion; timeline 6–8 months to proceed.

Q&A Highlights

• Gurgaon margins expected to be 23%+ in 2–3 years.
• Raipur break-even in 15–18 months; initial ~INR 20 crores operating loss.
• Daffodils hub-and-spoke consolidation for efficiency; ongoing expansion plans.
• Gurgaon occupancy to reach 50% in six months (management view).
• Post-expansion bed count around 900–960; occupancy target 70%–72%; potential 23%+ margins.

Meeting Details

• Date: Thursday, August 13, 2026
• Time: not disclosed
• Type/Mode: Group investor conference, in-person
• Event/Organizer: EMKAY Confluence 2026—Annual Investor Conference
• Location: Mumbai

Participants

• Company representatives: Company Secretary and Compliance Officer

Purpose

• Purpose: Investor interaction at annual conference

Meeting Details

• Date: August 13, 2026; Time: not specified.
• Event: EMKAY Confluence 2026: 'India: Full Throttle Ahead'; Investor conference.
• Location: Mumbai; Mode: Physical.
• Purpose: investor conference participation by company representatives.
• Key participants: company representatives (management).